학술논문
Visual Function Improvement in Patients With Macroprolactinomas Treated With Bromocriptine
Document Type
Article
Source
American Journal of Ophthalmology; May 1990, Vol. 109 Issue: 5 p535-543, 9p
Subject
Language
ISSN
00029394; 18791891
Abstract
We studied eight patients who had visual field defects secondary to prolactin-secreting macroadenomas and who had improved visual function with bromocriptine treatment without surgery or radiation. We recommend bromocriptine as a primary treatment for prolactin-secreting macroadenomas. If therapy is effective, continued regular neuro-ophthalmologic, endocrine, and imaging studies are necessary, because treatment with bromocriptine must be continued indefinitely.